Rice Hall James & Associates’s Medidata Solutions, Inc. MDSO Stock Holding History

Rice Hall James & Associates’s Portfolio MDSO Stock Details MDSO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q4	–	Sell	-384,762	Closed	-$35.2M	–	291
2019 Q3	$35.2M	Sell	384,762 -8,087	-2%	-$739K	1.26%	22
2019 Q2	$35.6M	Sell	392,849 -20,875	-5%	-$1.83M	1.18%	20
2019 Q1	$30.3M	Buy	413,724 +11,405	+3%	+$823K	0.98%	29
2018 Q4	$27.1M	Buy	402,319 +150,346	+60%	+$10.6M	0.99%	27
2018 Q3	$18.5M	Buy	251,973 +130,070	+107%	+$10.4M	0.66%	58
2018 Q2	$9.82M	Buy	+121,903	New	+$9.14M	0.36%	97

Other funds holding MDSO

WBC

Westpac Banking Corp Sydney, Australia $1.44B AUM 28.5% 1-Year Est. Return

Rice Hall James & Associates's MDSO Position: Q4 2019 in Review

Rice Hall James & Associates sold out of Medidata Solutions, Inc. (MDSO) in Q4 2019, closing a stake of 384,762 shares — an estimated $35.2M sold.

Rice Hall James & Associates first reported a position in MDSO in Q2 2018 and held it in 6 quarters. The position peaked at $35.6M in Q2 2019. 1 fund tracked by Wall St. Rank holds MDSO as of Q4 2019.

Rice Hall James & Associates reported no remaining Medidata Solutions, Inc. position as of Q4 2019 after selling out during the quarter.
Rice Hall James & Associates sold 384,762 Medidata Solutions, Inc. shares in Q4 2019, an estimated $35.2M.
Rice Hall James & Associates first reported a position in Medidata Solutions, Inc. in Q2 2018 and held it in 6 quarters.
Rice Hall James & Associates's Medidata Solutions, Inc. position peaked at $35.6M in Q2 2019.
1 fund tracked by Wall St. Rank held Medidata Solutions, Inc. as of Q4 2019.

Based on Rice Hall James & Associates's 13F filing for Q4 2019, filed 29 Jan 2020.